Rezafungin (CD101) demonstrates potent in vitro activity against Aspergillus, including azole-resistant Aspergillus fumigatus isolates and cryptic species

Overview of attention for article published in Journal of Antimicrobial Chemotherapy (JAC), July 2018

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (69th percentile)
Above-average Attention Score compared to outputs of the same age and source (61st percentile)

Mentioned by

twitter: 10 X users

Citations

dimensions_citation: 62 Dimensions

Readers on

mendeley: 31 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 10 X posts from 10 X users, with an upper bound of 84,895 followers.

Rezafungin (CD101) demonstrates potent in vitro activity against Aspergillus, including azole-resistant Aspergillus fumigatus isolates and cryptic species https://t.co/stYTPrqKbA

05 Oct 2019

Reply Repost Favourite

RT @GermHunterMD: #Rezafungin (CD101) demonstrates potent in vitro activity against #Aspergillus, including azole-resistant Aspergillus fu…

22 Jul 2018

Reply Repost Favourite

RT @GermHunterMD: #Rezafungin (CD101) demonstrates potent in vitro activity against #Aspergillus, including azole-resistant Aspergillus fu…

21 Jul 2018

Reply Repost Favourite

RT @GermHunterMD: #Rezafungin (CD101) demonstrates potent in vitro activity against #Aspergillus, including azole-resistant Aspergillus fu…

21 Jul 2018

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 6 additional X posts.